These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7233416)

  • 1. HLA in a selective aldosterone biosynthetic defect due to type 2 corticosterone methyl-oxidase deficiency.
    Brautbar C; Theodor R; Sack J; Levene C; Dupont B; Levine LS; Sharon R; Smaller S; Cohen T; Rösler A
    Tissue Antigens; 1981 Feb; 17(2):212-6. PubMed ID: 7233416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage and segregation analysis of HLA and congenital hypoaldosteronism due to corticosterone methyl-oxydase deficiency type I and type II.
    de Jongh BM; Veldhuis JD; Drop SL; Nijenhuis LE; Dupont B
    Tissue Antigens; 1984 Jul; 24(1):18-24. PubMed ID: 6592791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inborn error in the terminal step of aldosterone biosynthesis. Corticosterone methyl oxidase tpe II deficiency in a North American pedigree.
    Veldhuis JD; Kulin HE; Santen RJ; Wilson TE; Melby JC
    N Engl J Med; 1980 Jul; 303(3):117-21. PubMed ID: 6991942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biochemical phenotypes of two inborn errors in the biosynthesis of aldosterone.
    Ulick S; Wang JZ; Morton DH
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1415-20. PubMed ID: 1592889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated aldosterone deficiency in man: acquired and inborn errors in the biosynthesis or action of aldosterone.
    Veldhuis JD; Melby JC
    Endocr Rev; 1981; 2(4):495-517. PubMed ID: 6273148
    [No Abstract]   [Full Text] [Related]  

  • 6. Congenitally defective aldosterone biosynthesis in humans: inactivation of the P-450C18 gene (CYP11B2) due to nucleotide deletion in CMO I deficient patients.
    Mitsuuchi Y; Kawamoto T; Miyahara K; Ulick S; Morton DH; Naiki Y; Kuribayashi I; Toda K; Hara T; Orii T
    Biochem Biophys Res Commun; 1993 Feb; 190(3):864-9. PubMed ID: 8439335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical diagnosis and management of corticosterone methyl oxidase type II deficiency.
    Lee PD; Patterson BD; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1986 Jan; 62(1):225-9. PubMed ID: 3510001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inborn errors of aldosterone biosynthesis in humans.
    Shizuta Y; Kawamoto T; Mitsuuchi Y; Miyahara K; Rösler A; Ulick S; Imura H
    Steroids; 1995 Jan; 60(1):15-21. PubMed ID: 7792802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency.
    Pascoe L; Curnow KM; Slutsker L; Rösler A; White PC
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4996-5000. PubMed ID: 1594605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation THR-185 ILE is associated with corticosterone methyl oxidase deficiency type II.
    Peter M; Bünger K; Sólyom J; Sippell WG
    Eur J Pediatr; 1998 May; 157(5):378-81. PubMed ID: 9625333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inherited defect in aldosterone biosynthesis caused by a mutation in or near the gene for steroid 11-hydroxylase.
    Globerman H; Rösler A; Theodor R; New MI; White PC
    N Engl J Med; 1988 Nov; 319(18):1193-7. PubMed ID: 3262827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosterone synthase) causes corticosterone methyl oxidase II deficiency.
    Zhang G; Rodriguez H; Fardella CE; Harris DA; Miller WL
    Am J Hum Genet; 1995 Nov; 57(5):1037-43. PubMed ID: 7485152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosterone methyl oxidase type II (CMO II) deficiency: biochemical approach to diagnosis.
    Yong AB; Montalto J; Pitt J; Oakes S; Preston T; Buchanan C
    Clin Biochem; 1994 Dec; 27(6):491-4. PubMed ID: 7697895
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective hypoaldosteronism in Iranian Jews: An autosomal recessive trait.
    Cohen T; Theodor R; Rösler A
    Clin Genet; 1977 Jan; 11(1):25-30. PubMed ID: 830445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenitally defective aldosterone biosynthesis in humans: the involvement of point mutations of the P-450C18 gene (CYP11B2) in CMO II deficient patients.
    Mitsuuchi Y; Kawamoto T; Naiki Y; Miyahara K; Toda K; Kuribayashi I; Orii T; Yasuda K; Miura K; Nakao K
    Biochem Biophys Res Commun; 1992 Jan; 182(2):974-9. PubMed ID: 1346492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital hypoaldosteronism: the Visser-Cost syndrome revisited.
    Peter M; Sippell WG
    Pediatr Res; 1996 Mar; 39(3):554-60. PubMed ID: 8929880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Variability of corticosterone methyl oxidase (type II) deficiency. Presentation of three case reports].
    Rosendahl W; König M; Haack D; Vecsei P; Lewicka S
    Klin Padiatr; 1993; 205(3):180-4. PubMed ID: 8350592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous deletion of arginine-173 in the CYP11B2 gene in a girl with congenital hypoaldosteronism. Corticosterone methyloxidase deficiency type II.
    Peter M; Nikischin W; Heinz-Erian P; Fussenegger W; Kapelari K; Sippell WG
    Horm Res; 1998; 50(4):222-5. PubMed ID: 9838244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group.
    Levine LS; Zachmann M; New MI; Prader A; Pollack MS; O'Neill GJ; Yang SY; Oberfield SE; Dupont B
    N Engl J Med; 1978 Oct; 299(17):911-5. PubMed ID: 692595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Dupont B; Oberfield SE; Smithwick EM; Lee TD; Levine LS
    Lancet; 1977 Dec 24-31; 2(8052-8053):1309-12. PubMed ID: 74726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.